Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 10, 2021

View Archived Issues

Allena initiates two phase II trials of its engineered urate oxidase, ALLN-346

TRACON presents safety data review results for ENVASARC pivotal trial of envafolimab

First patient dosed in phase Ib/II study of AVB-500 in pancreatic adenocarcinoma

Korea Institute of Science and Technology identifies TNK2/MAP4K2 inhibitors

Shanghai Hengrui Pharmaceutical, Jiangsu Hengrui Medicine patent ATR kinase inhibitors

New PIN1 inhibitors discovered at Pimedbio, DGMIF

Gruenenthal divulges glucocorticoid receptor modulators

Phase II MERIT study of AXS-05 achieves primary and key secondary endpoints

Trillium initiates dosing of patients with TP53-mutated AML in phase Ib/II study of TTI-622

Otsuka receives a grant for phase II study of OPC-167832 plus delamanid and bedaquiline

NRx initiates phase IIb study of BriLife COVID-19 vaccine in Georgia

SPNS2 inhibition may be useful in treating autoimmune disease

Sorrento presents development of multivalent mRNA COVID-19 vaccine

Emory University tests yeast-expressed SARS-CoV-2-specific RBD-based vaccine in rhesus macaques

AAV2-hAADC gene therapy shows safety and efficacy in children with AADC deficiency

Stress hormones affect brain plasticity via distinct mechanisms

Ohio State University describes looped proteins comprising cell-penetrating peptides

First patient dosed in phase I study of APL-102

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...